Navigation Links
Cognitive Therapy Helps Adults With ADHD
Date:8/25/2010

By Amanda Gardner
HealthDay Reporter

TUESDAY, Aug. 24 (HealthDay News) -- Adding therapy to the medications an adult might be taking for attention-deficit/hyperactivity disorder (ADHD) could lessen symptoms and improve quality of life, new research suggests.

After one year, patients receiving cognitive behavioral therapy along with their medications quelled persistent symptoms better than using drugs plus relaxation exercises.

"We have known that therapy helps, but this study shows that it's not just sitting with someone and talking about ADHD but specifically cognitive behavioral therapy that's helpful," said Jon Bergeron Jr., an assistant professor of psychiatry and behavioral science at Texas A&M Health Science Center College of Medicine and a psychologist with Scott & White College Station Clinic.

Whether or not patients actually pursue a professional's recommendation to start therapy is another matter.

"Most people don't pursue therapy," Bergeron stated. "Our culture is always looking for a magic pill."

Bergeron was not involved with the study, which appears in the Aug. 25 issue of the Journal of the American Medical Association.

Medications such as the stimulant Ritalin are the first course of treatment for ADHD.

But the majority of patients still have some symptoms even after being prescribed drugs, said study author Steven A. Safren, director of behavioral medicine in the department of psychiatry at Massachusetts General Hospital in Boston.

After a pilot study of cognitive behavioral therapy and ADHD was successful, Safren and his colleagues decided to embark on a larger study.

This randomized, controlled trial involved 86 adults with ADHD already on medication who were randomized to receive 12 sessions of cognitive behavioral therapy (CBT) or combined educational/relaxation support.

The CBT involved learning how to address tasks throughout the day and think more flexibly. The control group involved education and muscle and other relaxation techniques.

Seventy of the participants were included in the final analysis.

Patients in the CBT group saw more relief of their symptoms than those in the control group as assessed by several different scales. The improvements lasted the whole year.

Safren does not see CBT replacing drugs as a mainstay of ADHD treatment.

"ADHD is a neurobiological disorder, but this might help in addition to medication and we may be able to do this in people who can't tolerate drugs," he said.

The questions are whether patients will go for it and whether insurance companies will pay for it.

But, said Bergeron, "this is proof that [CBT] does make a difference in someone's life."

More information

The U.S. National Institute of Mental Health has more on ADHD.

SOURCES: Steven A. Safren, Ph.D., director, behavioral medicine, department of psychiatry, Massachusetts General Hospital, Boston; Jon Bergeron Jr., Ph.D., assistant professor, psychiatry and behavioral science, Texas A&M Health Science Center College of Medicine, and psychologist, Scott & White College Station Clinic; Aug. 25, 2010, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Moderate drinking, especially wine, associated with better cognitive function
2. Culture wires the brain: A cognitive neuroscience perspective
3. Heart bypass for uncomplicated heart surgery does not reduce neurocognitive function in children
4. Medications found to cause long term cognitive impairment of aging brain
5. Mayo Clinic study finds apathy and depression predict progression from mild cognitive impairment
6. Predicting Alzheimers Risk in Patients With Cognitive Problems
7. Teenage physical activity reduces risk of cognitive impairment in later life
8. Memory problems not the only predictor of later mild cognitive impairment
9. Cold sore virus may contribute to cognitive and brain abnormalities in schizophrenia
10. New evidence caffeine may slow Alzheimers disease and other dementias, restore cognitive function
11. Sickle Cell Disease Tied to Cognitive Difficulties
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cognitive Therapy Helps Adults With ADHD 
(Date:6/23/2017)... ... June 23, 2017 , ... ... Conference from Sept. 18 to 20. , The two-day conference is focused on ... the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. The ...
(Date:6/23/2017)... ... , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves clients ... (FEMA) recent update of flood zones, more people than ever are in flood ... to reflect the actual risk in flood zone areas during a time when ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, ... communities in the greater Chicago metropolitan area, is embarking on a charity drive ... in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of the ...
(Date:6/22/2017)... FL (PRWEB) , ... June 22, 2017 , ... Branches, ... received more than $245,000 in grant funding to support its programs focused on providing ... Branches, Inc. was awarded a grant by the Foundation of $15,000 to support its ...
(Date:6/22/2017)... ... June 22, 2017 , ... Children’s National Health System ... (AHA) to launch a Rheumatic Heart Disease Center, with the goal of developing ... heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that the U.S. Food and Drug Administration ... June 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning ... manufacturing facility is a measure of the progress we ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
Breaking Medicine Technology: